Your browser doesn't support javascript.
loading
Human IL-23 is essential for IFN-γ-dependent immunity to mycobacteria.
Philippot, Quentin; Ogishi, Masato; Bohlen, Jonathan; Puchan, Julia; Arias, Andrés Augusto; Nguyen, Tina; Martin-Fernandez, Marta; Conil, Clement; Rinchai, Darawan; Momenilandi, Mana; Mahdaviani, Seyed Alireza; Keramatipour, Mohammad; Rosain, Jérémie; Yang, Rui; Khan, Taushif; Neehus, Anna-Lena; Materna, Marie; Han, Ji Eun; Peel, Jessica; Mele, Federico; Weisshaar, Marc; Jovic, Sandra; Bastard, Paul; Lévy, Romain; Le Voyer, Tom; Zhang, Peng; Maglorius Renkilaraj, Majistor Raj Luxman; Arango-Franco, Carlos A; Pelham, Simon; Seeleuthner, Yoann; Pochon, Mathieu; Ata, Manar Mahmoud Ahmad; Al Ali, Fatima; Migaud, Mélanie; Soudée, Camille; Kochetkov, Tatiana; Molitor, Anne; Carapito, Raphael; Bahram, Seiamak; Boisson, Bertrand; Fieschi, Claire; Mansouri, Davood; Marr, Nico; Okada, Satoshi; Shahrooei, Mohammad; Parvaneh, Nima; Chavoshzadeh, Zahra; Cobat, Aurélie; Bogunovic, Dusan; Abel, Laurent.
Afiliação
  • Philippot Q; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Ogishi M; University Paris Cité, Imagine Institute, Paris, France.
  • Bohlen J; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
  • Puchan J; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Arias AA; University Paris Cité, Imagine Institute, Paris, France.
  • Nguyen T; Institute of Microbiology, ETH Zürich, Zürich, Switzerland.
  • Martin-Fernandez M; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
  • Conil C; Primary Immunodeficiencies Group, University of Antioquia (UdeA), Medellin, Colombia.
  • Rinchai D; School of Microbiology, University of Antioquia (UdeA), Medellin, Colombia.
  • Momenilandi M; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
  • Mahdaviani SA; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.
  • Keramatipour M; Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Rosain J; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Yang R; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Khan T; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Neehus AL; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Materna M; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Han JE; University Paris Cité, Imagine Institute, Paris, France.
  • Peel J; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
  • Mele F; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Weisshaar M; University Paris Cité, Imagine Institute, Paris, France.
  • Jovic S; Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Bastard P; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Lévy R; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Le Voyer T; University Paris Cité, Imagine Institute, Paris, France.
  • Zhang P; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
  • Maglorius Renkilaraj MRL; Department of Human Immunology, Sidra Medicine, Doha, Qatar.
  • Arango-Franco CA; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Pelham S; University Paris Cité, Imagine Institute, Paris, France.
  • Seeleuthner Y; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Pochon M; University Paris Cité, Imagine Institute, Paris, France.
  • Ata MMA; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
  • Al Ali F; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
  • Migaud M; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Soudée C; Institute of Microbiology, ETH Zürich, Zürich, Switzerland.
  • Kochetkov T; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Molitor A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Carapito R; University Paris Cité, Imagine Institute, Paris, France.
  • Bahram S; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
  • Boisson B; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France.
  • Fieschi C; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Mansouri D; University Paris Cité, Imagine Institute, Paris, France.
  • Marr N; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France.
  • Okada S; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Shahrooei M; University Paris Cité, Imagine Institute, Paris, France.
  • Parvaneh N; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
  • Chavoshzadeh Z; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Cobat A; University Paris Cité, Imagine Institute, Paris, France.
  • Bogunovic D; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Abel L; Primary Immunodeficiencies Group, University of Antioquia (UdeA), Medellin, Colombia.
Sci Immunol ; 8(80): eabq5204, 2023 02 17.
Article em En | MEDLINE | ID: mdl-36763636
ABSTRACT
Patients with autosomal recessive (AR) IL-12p40 or IL-12Rß1 deficiency display Mendelian susceptibility to mycobacterial disease (MSMD) due to impaired IFN-γ production and, less commonly, chronic mucocutaneous candidiasis (CMC) due to impaired IL-17A/F production. We report six patients from four kindreds with AR IL-23R deficiency. These patients are homozygous for one of four different loss-of-function IL23R variants. All six patients have a history of MSMD, but only two suffered from CMC. We show that IL-23 induces IL-17A only in MAIT cells, possibly contributing to the incomplete penetrance of CMC in patients unresponsive to IL-23. By contrast, IL-23 is required for both baseline and Mycobacterium-inducible IFN-γ immunity in both Vδ2+ γδ T and MAIT cells, probably contributing to the higher penetrance of MSMD in these patients. Human IL-23 appears to contribute to IL-17A/F-dependent immunity to Candida in a single lymphocyte subset but is required for IFN-γ-dependent immunity to Mycobacterium in at least two lymphocyte subsets.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon gama / Interleucina-23 / Mycobacterium / Infecções por Mycobacterium Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon gama / Interleucina-23 / Mycobacterium / Infecções por Mycobacterium Idioma: En Ano de publicação: 2023 Tipo de documento: Article